INSULIN-LIKE GROWTH FACTOR AND EPIDERMAL GROWTH FACTOR TREATMENT: NEW APPROACHES TO PROTECTING STEATOTIC LIVERS AGAINST ISCHEMIA-REPERFUSION INJURY.
The Department investigates the molecular basis and signaling pathways associated with damage and repair in ischemic and inflammatory-based diseases associated with abdominal organs (liver, pancreas, and kidney), cancer, and cardiovascular disease but also other. idiopathic diseases such as pulmonary fibrosis.